{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:04:25Z","timestamp":1790949865435,"version":"4.1.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T00:00:00Z","timestamp":1646956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"National Institute for Health Research Manchester Biomedical Research Centre Funding Scheme"},{"name":"National Health Service"},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004856","name":"Department of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015391","name":"The Myositis Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012041","name":"Versus Arthritis","doi-asserted-by":"publisher","award":["21993"],"award-info":[{"award-number":["21993"]}],"id":[{"id":"10.13039\/501100012041","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute for Health Research Manchester Biomedical Research Centre"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>The objective of this study was to use daily data collected via a smartphone app for characterization of patient-reported and symptom-based (using an a priori definition) flares in an adult idiopathic inflammatory myopathy (IIM) cohort.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>UK adults with an IIM answered patient-reported outcome measurements (PROMs) daily via a smartphone app during a 91-day study. Daily symptom PROMs addressed global activity, overall pain, myalgia, fatigue, and weakness (on a 0\u2013100 visual analogue scale). Patient-reported flares were recorded via a weekly app question. Symptom-based flares were defined via an a priori definition related to increase in daily symptom data from the previous 4-day mean.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Twenty participants (65% female) participated. Patient-reported flares occurred on a median of 5\u2009weeks (IQR 3, 7) per participant, out of a possible 13. The mean of each symptom score was significantly higher in flare weeks, compared with non-flare weeks (e.g. mean flare week myalgia score 34\/100, vs 21\/100 during non-flare week, t test P-value &amp;lt;0.01). Fatigue accounted for the most symptom-based flares [incidence-rate 23\/100 person-days (95% CI 19, 27)], and myalgia the fewest [incidence rate 13\/100 person-days (95% CI 11, 16)]. Symptom-based flares typically resolved after 3\u2009days, although fatigue-predominant flares lasted 2\u2009days. The majority (69%) of patient-reported flare weeks coincided with at least one symptom-based flare.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>IIM flares are frequent and associated with increased symptom scores. This study has demonstrated the ability to identify and characterize patient-reported and symptom-based flares (based on an a priori definition), using daily app-collected data.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keac161","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T20:11:30Z","timestamp":1646943090000},"page":"4845-4854","source":"Crossref","is-referenced-by-count":11,"title":["Investigating characteristics of idiopathic inflammatory myopathy flares using daily symptom data collected via a smartphone app"],"prefix":"10.1093","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5701-6490","authenticated-orcid":false,"given":"Alexander G S","family":"Oldroyd","sequence":"first","affiliation":[{"name":"NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust"},{"name":"Centre for Musculoskeletal Research, University of Manchester, Manchester Academic Health Science Centre"},{"name":"Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, University of Manchester, Manchester"},{"name":"Department of Rheumatology, Salford Royal Hospital , Salford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels Steen","family":"Krogh","sequence":"additional","affiliation":[{"name":"ZiteLab , Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5881-4857","authenticated-orcid":false,"given":"William G","family":"Dixon","sequence":"additional","affiliation":[{"name":"Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, University of Manchester, Manchester"},{"name":"Department of Rheumatology, Salford Royal Hospital , Salford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6492-1288","authenticated-orcid":false,"given":"Hector","family":"Chinoy","sequence":"additional","affiliation":[{"name":"NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust"},{"name":"Centre for Musculoskeletal Research, University of Manchester, Manchester Academic Health Science Centre"},{"name":"Department of Rheumatology, Salford Royal Hospital , Salford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,3,11]]},"reference":[{"key":"2022112912432048600_keac161-B1","doi-asserted-by":"crossref","first-page":"322","DOI":"10.7861\/clinmedicine.17-4-322","article-title":"Idiopathic inflammatory myopathies \u2013 a guide to subtypes, diagnostic approach and treatment","volume":"17","author":"Oldroyd","year":"2017","journal-title":"Clin Med"},{"key":"2022112912432048600_keac161-B2","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/med\/9780199642489.003.0124_update_002","volume-title":"Oxford textbook of rheumatology","author":"Chinoy","year":"2013"},{"key":"2022112912432048600_keac161-B3","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.joca.2019.04.003","article-title":"\u2018Acute flare-ups\u2019 in patients with, or at high risk of, knee osteoarthritis: a daily diary study with case\u2013crossover analysis","volume":"27","author":"Parry","year":"2019","journal-title":"Osteoarthr Cartil"},{"key":"2022112912432048600_keac161-B4","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jaci.2015.07.028","article-title":"Asthma Flare-up Diary for Young Children to monitor the severity of exacerbations","volume":"137","author":"Ducharme","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"2022112912432048600_keac161-B5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41746-019-0111-3","article-title":"Digital health: a path to validation","volume":"2","author":"Mathews","year":"2019","journal-title":"NPJ Digit Med"},{"key":"2022112912432048600_keac161-B6","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1007\/s00296-018-4037-x","article-title":"Digital health: a new dimension in rheumatology patient care","volume":"38","author":"Kataria","year":"2018","journal-title":"Rheumatol Int"},{"key":"2022112912432048600_keac161-B7","author":"Pew Research Center. Mobile Fact Sheet","year":"2018"},{"key":"2022112912432048600_keac161-B8","author":"Ofcom","year":"2018"},{"key":"2022112912432048600_keac161-B9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/rheumatology\/kez207","article-title":"Providing \u2018the bigger picture\u2019: benefits and feasibility of integrating remote monitoring from smartphones into the electronic health record: findings from the Remote Monitoring of Rheumatoid Arthritis (REMORA) study","volume":"59","author":"Austin","year":"2020","journal-title":"Rheumatology"},{"key":"2022112912432048600_keac161-B10","doi-asserted-by":"crossref","first-page":"e11568","DOI":"10.2196\/11568","article-title":"Development and long-term acceptability of ExPRESS, a mobile phone app to monitor basic symptoms and early signs of psychosis relapse","volume":"7","author":"Eisner","year":"2019","journal-title":"JMIR mHealth uHealth"},{"key":"2022112912432048600_keac161-B11","article-title":"Clinician-Input Study (CIS-PD): how the Fox Wearable Companion Application can influence treatment and care in Parkinson\u2019s disease (P3.048)","volume":"90(Suppl 15","author":"Daeschler","year":"2018","journal-title":"Neurology"},{"key":"2022112912432048600_keac161-B12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s41927-020-00146-3","article-title":"Patient insights on living with idiopathic inflammatory myopathy and the limitations of disease activity measurement methods \u2013 a qualitative study","volume":"4","author":"Oldroyd","year":"2020","journal-title":"BMC Rheumatol"},{"key":"2022112912432048600_keac161-B13","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2022112912432048600_keac161-B14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"224th ENMC International Workshop: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14\u201316 October 2016","volume":"28","author":"Allenbach","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"2022112912432048600_keac161-B15","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/acr.22606","article-title":"Determining the minimally important difference in the clinical disease activity index for improvement and worsening in early rheumatoid arthritis patients","volume":"67","author":"Curtis","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2022112912432048600_keac161-B16","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.3899\/jrheum.090193","article-title":"The minimally important difference for patient reported outcomes in systemic lupus erythematosus including the HAQ-DI, pain, fatigue, and SF-36","volume":"36","author":"Colangelo","year":"2009","journal-title":"J\u00a0Rheumatol"},{"key":"2022112912432048600_keac161-B17","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.3899\/jrheum.080375","article-title":"The minimally important difference for the fatigue visual analog scale in patients with rheumatoid arthritis followed in an academic clinical practice","volume":"35","author":"Khanna","year":"2008","journal-title":"J\u00a0Rheumatol"},{"key":"2022112912432048600_keac161-B18","article-title":"Patient-reported outcome measures for rheumatoid arthritis: minimal important differences review","volume":"65","author":"Kitchen","year":"2013","journal-title":"Arthritis Rheumatol"},{"key":"2022112912432048600_keac161-B19","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1002\/acr.21747","article-title":"Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: results from a prospective multina","volume":"64","author":"Tubach","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2022112912432048600_keac161-B20","author":"R Core Team","year":"2014"},{"key":"2022112912432048600_keac161-B21","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3899\/jrheum.131247","article-title":"Patient-reported outcomes and adult patients\u2019 disease experience in the idiopathic inflammatory myopathies. Report from the OMERACT 11 myositis special interest group","volume":"41","author":"Alexanderson","year":"2014","journal-title":"J Rheumatol"},{"key":"2022112912432048600_keac161-B22","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.3899\/jrheum.161252","article-title":"Advancing the development of patient-reported outcomes for adult myositis at OMERACT 2016: an international Delphi study","volume":"44","author":"Park","year":"2017","journal-title":"J Rheumatol"},{"key":"2022112912432048600_keac161-B23","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.3899\/jrheum.141243","article-title":"Patients\u2019 experience of myositis and further validation of a myositis-specific patient reported outcome measure \u2013 establishing core domains and expanding patient input on clinical assessment in myositis. Report from OMERACT 12","volume":"42","author":"Regardt","year":"2015","journal-title":"J Rheumatol"},{"key":"2022112912432048600_keac161-B24","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3899\/jrheum.180353","article-title":"Perceptions of patients, caregivers, and healthcare providers of idiopathic inflammatory myopathies: an international OMERACT study","volume":"46","author":"Mecoli","year":"2019","journal-title":"J\u00a0Rheumatol"},{"key":"2022112912432048600_keac161-B25","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00296-020-04634-0","article-title":"Trends in idiopathic inflammatory myopathies: cross-sectional data from the German National Database","volume":"40","author":"Albrecht","year":"2020","journal-title":"Rheumatol Int"},{"key":"2022112912432048600_keac161-B26","first-page":"99","article-title":"Responsiveness to change of 5-point MRC scale, endurance and functional evaluation for assessing myositis in daily clinical practice","volume":"6","author":"Landon-Cardinal","year":"2019","journal-title":"J\u00a0Neuromuscul Dis"},{"key":"2022112912432048600_keac161-B27","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1093\/rheumatology\/keaa076","article-title":"Follow-up results of myositis patients treated with H. P. Acthar gel","volume":"59","author":"Saygin","year":"2020","journal-title":"Rheumatology"},{"key":"2022112912432048600_keac161-B28","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1093\/rheumatology\/kex162","article-title":"Environmental factors associated with disease flare in juvenile and adult dermatomyositis","volume":"56","author":"Mamyrova","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2022112912432048600_keac161-B29","first-page":"1424","article-title":"Patient-reported dermatomyositis and polymyositis flare symptoms are associated with disability, productivity loss, and health care resource use","volume":"26","author":"Christopher-Stine","year":"2020","journal-title":"J Manag Care Spec Pharm"},{"key":"2022112912432048600_keac161-B30","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.3899\/jrheum.110401","article-title":"Identifying preliminary domains to detect and measure rheumatoid arthritis flares: report of the OMERACT 10 RA Flare Workshop","volume":"38","author":"Bingham","year":"2011","journal-title":"J Rheumatol"},{"key":"2022112912432048600_keac161-B31","doi-asserted-by":"crossref","first-page":"e000225","DOI":"10.1136\/rmdopen-2015-000225","article-title":"Identifying flares in rheumatoid arthritis: reliability and construct validation of the OMERACT RA Flare Core Domain Set","volume":"2","author":"Bykerk","year":"2016","journal-title":"RMD Open"},{"key":"2022112912432048600_keac161-B32","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1136\/annrheumdis-2011-201201","article-title":"Identifying core domains to assess flare in rheumatoid arthritis: an OMERACT international patient and provider combined Delphi consensus","volume":"71","author":"Bartlett","year":"2012","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac161\/43330287\/keac161.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/12\/4845\/47385895\/keac161.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/12\/4845\/47385895\/keac161.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T12:44:33Z","timestamp":1669725873000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/61\/12\/4845\/6547044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,11]]},"references-count":32,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,3,11]]},"published-print":{"date-parts":[[2022,11,28]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac161","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,12,1]]},"published":{"date-parts":[[2022,3,11]]}}}